Scge Management, L.P. Bridge Bio Pharma, Inc. Transaction History

Scge Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.96 - $46.63 $7.47 Million - $19.4 Million	-415,978 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.13 - $32.38 $3.47 Million - $5.58 Million	-172,257 Reduced 29.28%	415,978 $8.93 Million
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $15.9 Million - $16.2 Million	588,235 New	588,235 $15.9 Million

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Scge Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Scge Management, L.P. with notifications on news.